Start Here — Who Are You and What Keeps You Busy?

• What is your role and primary area of responsibility for sample logistics? Options: Clinical Supply Director, Biorepository/Bank Director, Quality Assurance Lead, Project Manager, Laboratory Operations Lead, Other
• Roughly how many clinical sites and countries does your program span? Options: 0–25 sites, 26–100 sites, 101–500 sites, 501–2000 sites, 2000+ sites
• Which systems do you actively use to track samples today (select all that apply)? Options: LIMS, CTMS, ERP / supply chain system, Courier portal(s), Custom internal dashboard, None / spreadsheet-based, Other
• Which KPIs are you measured on for sample logistics? Options: On-time receipt, Temperature integrity, Chain-of-custody completeness, Sample viability / assay success, Customs clearance time, Cost per shipment, Other
• Describe a recent shipment or program moment that still sticks with you — good or bad. What happened?

Who Really Holds the Keys When Something Breaks?

• When a sample’s fate is uncertain, which team or role is typically expected to make the call? Options: Clinical Operations, QA/Regulatory, Central Lab Operations, Supply Chain/Logistics, Vendor/Courier, Steering Committee, Other
• List the primary stakeholders (internal and external) who must be aligned before a shipping SOP or vendor decision is finalized. Options: Clinical Ops, QA/RA, Lab Directors, Site Coordinators, Procurement, Vendors/Couriers, IT/Integration, Other
• Who legally owns sample data and who signs off for regulatory acceptance in your organization? Options: Sponsor / Pharma, CRO, Central Lab, Biorepository, Shared ownership, Unclear / varies by program, Other
• How fast do alignment decisions need to be made when a protocol or supply flow changes? Options: Within days, 1–2 weeks, 2–4 weeks, Longer than a month, Depends on change
• Give an example of a time stakeholder misalignment delayed a decision — who was left out and what did it cost?
• What notification and escalation methods keep stakeholders engaged without overwhelming them? Options: Email summaries, Real-time alerts (SMS/phone), Weekly governance calls, Shared dashboards, Ad-hoc meetings, Other

The Cold Hard Truth About Your Sample Flow

• If you replayed your last failed shipment frame-by-frame, where would it most likely break first? Options: At collection (labeling/handling), During local pickup/courier handoff, Customs/transport delays, During transit (temperature loss), At receiving (logging errors), Other
• Map the usual sample path from site to final destination — what systems, handoffs, and checkpoints are in that chain?
• Which failure modes show up most often in your program? Options: Temperature excursions, Mislabeling / ID mismatch, Incomplete chain-of-custody (COC), Barcode scanning errors, Missing shipping paperwork, Custody handoff gaps, Other
• How frequently do you experience temperature excursions or integrity exceptions? Options: Weekly, Monthly, Quarterly, Rarely, Never documented
• When an exception occurs, how long does it take on average to reconstruct the chain-of-custody and produce audit evidence? Options: <24 hours, 1–3 days, 4–10 days, >10 days, Unable to reconstruct
• What parts of the audit trail are most often missing or weak? Options: Time-stamped scans, Temperature logs, Courier handover signatures, Customs documentation, Lab receiving records, Complete COC, Other

What Keeps You Awake at 2am?

• Which single failure would cause the most serious regulatory or program damage for you? Options: Irreversible sample loss, Invalidation of primary endpoint data, Major protocol deviation, Regulatory inspection finding, Chain-of-custody integrity question, Other
• Have you faced regulatory findings tied to sample logistics—what were they and how were they resolved? Options: Yes, major, Yes, minor, No, Not sure / pending
• Quantify the downstream impact when a critical sample issue occurs (time lost, added cost, trial delay).
• How does persistent logistics risk affect your relationship with sites, labs, and internal teams?
• Emotionally, how much tolerance does your team have for repeat exceptions before you seek a new provider or process? Options: Zero tolerance, Low tolerance, Moderate tolerance, High tolerance

If Success Had a Nameplate — Define It

• When you hear “audit-ready chain-of-custody,” what exact evidence must exist to satisfy your regulators? Options: Time-stamped scans at every handoff, Continuous temperature logs, Signed COCs per transfer, Integrated LIMS records, Courier proof-of-delivery, Other
• Which KPIs must be achieved for you to consider a vendor successful? Options: >98% on-time receipt, 0 temperature excursions, >99% COC completeness, <24-hour exception resolution, Real-time tracking for all shipments, Other
• Which of these are regulatory requirements versus internal performance preferences? Options: Regulatory requirement, Internal preference, Both, Unsure
• Who in your organization signs off that outcomes meet regulatory acceptance? Options: QA/RA, Clinical Head, Lab Director, Combined sign-off, Other
• Are there program-specific acceptance thresholds (e.g., temp tolerance ±X°C, allowable transit windows)? Please list them.

Imagine the Worst Transit Day — Then Fix It

• If a full transit failure happened (lost custody + temperature excursion + paperwork gap), who would you expect to lead the recovery and communication? Options: Vendor/courier, Sponsor clinical ops, QA, Central lab, Cross-functional war room, Other
• Describe the minimum evidence and steps you would require for disposition decisions after an excursion.
• What are your expectations for alerting and response SLAs when a temperature alarm or custody exception fires? Options: Instant alert + 1-hr response, 1–4 hour initial response, Same business day, 24–48 hours, Other
• Who is authorized to approve sample quarantine, re-test, or destruction, and what documentation do they need? Options: QA, Medical Monitor, Lab Director, Sponsor, Other
• Would you accept conditional recovery actions (e.g., extended stability data) in lieu of re-collection? Under what evidence standards? Options: Yes, with stability data, Yes, with lab validation, No, re-collection required, Depends on sample type

How Connected Does Your World Need to Be?

• If LIMS/CTMS couldn't receive real-time courier updates, what critical workflows would break first? Options: Sample receiving, COC reconciliation, Temperature exception triage, Data lock / analysis, Regulatory reporting, Other
• Which integrations are mandatory for go-live (select all that apply)? Options: LIMS, CTMS, Sponsor portal, ERP/finance, Courier APIs, SFTP batch file ingestion, Single Sign-On (SSO)
• What data fields must be exchanged in real time (examples: sample ID, timestamped custody event, temperature profile, GPS, POD)?
• What are your security/validation expectations for integrations (e.g., 21 CFR Part 11, SOC2, encryption, IQ/OQ/PQ)? Options: 21 CFR Part 11, SOC2, ISO 27001, Encrypted API / TLS, IQ/OQ/PQ qualification, Other
• How much lead time and internal IT involvement do you realistically have for integration testing? Options: <2 weeks, 2–4 weeks, 1–3 months, 3+ months, IT not available

Regulatory Confidence — Will Your Records Stand Up?

• Would you be comfortable submitting current chain-of-custody samples and logs as-is to an auditor? Options: Yes, fully confident, Somewhat confident, Not confident, Never been audited
• What documentation is missing today when auditors ask for a complete trail? Options: Signed COCs, Timestamped scans, Temperature certification, Courier SOPs, Receiving logs, Training records, Other
• Have you had regulatory comments tied to logistics? What corrective actions were required? Options: Yes, CAPA required, Yes, minor corrections, No, Not sure
• What retention periods and archival formats does your QA team require for logistics records? Options: 3 years, 5 years, 15 years, Project-specific, Other
• What level of vendor documentation and audit deliverables would satisfy your QA sign-off (SOPs, 3rd-party audits, test reports)? Options: Full SOPs + audits, Redacted SOPs + attestations, On-demand evidence, Minimal documentation, Other

Scope, Responsibilities & Boundaries — Who Does What?

• Which service modules do you expect a provider to own versus what you will retain in-house? Options: Kit provisioning, Packaging & thermal validation, Global courier coordination, Temperature monitoring & alerts, Receiving & logging, Biorepository storage, Customs clearance, Other
• For each module you expect us to own, what measurable acceptance criteria would you require?
• Who will own customs and import/export compliance responsibilities for cross-border shipments? Options: Vendor, Sponsor/CRO, Shared, Third-party customs broker, Other
• What are your expectations for SLA granularity (program-level vs. per-shipment vs. per-region)? Options: Program-level SLAs, Per-shipment SLAs, Per-region SLAs, Combination, Unsure
• Are there non-negotiable exclusions or service boundaries your team requires (e.g., no third-party sub-carriers, temperature tolerances)?

Timing, Budget & Commitment — What Would Make This Real?

• If the program needed to go live urgently, what is the earliest realistic go-live you could support? Options: Immediately / <2 weeks, 2–4 weeks, 1–3 months, 3–6 months, 6+ months
• What is the procurement path and typical budget approval timeline for logistics vendors in your organization? Options: Direct purchase (fast), Procurement RFP (weeks), Formal tender (months), Corporate sourcing required (months), Other
• Which pricing model do you prefer for sample logistics? Options: Per-shipment, Subscription, Blended (per-shipment + platform fee), Capitated / fixed, Other
• Would you require a pilot or proof-of-concept before full rollout? If yes, what success criteria would you demand? Options: No pilot, Short pilot (10–50 shipments), Regional pilot, Pilot with formal acceptance criteria, Other
• Who are the signatories and approvers needed to finalize a mutual commit for this work? Options: Procurement, QA/RA, Clinical Ops, Legal, Finance, Vendor sign-off, Other

Proof in the Pudding — Stories That Matter

• Tell us about a vendor or internal team that exceeded expectations on a logistics issue — what did they do differently?
• What specific evidence or deliverables from that positive experience would you want to see replicated here? Options: Runbook + war room, Post-event root-cause analysis, Compensation / SLA credit, Improved SOPs, Training for sites, Other
• Conversely, describe a vendor shortfall that made you lose trust — what warning signs would you want to avoid?
• Which reference checks or case studies would most influence your confidence (similar indication, similar geography, audit-ready artifacts)? Options: Same therapeutic area, Same geographic coverage, Same sample type, Regulatory-ready audit evidence, Customer testimonials, Other
• What are the single most persuasive proof points that would make your team comfortable switching providers?

Deciding Together — What Would Make You Say Yes?

• What are the top three decision criteria you will use when selecting a partner for this program? Options: Regulatory compliance / audit history, Global network coverage, Temperature monitoring tech, Integration capability, Cost, Responsiveness / escalation, Other
• What timeline and steps constitute a winning RFP/evaluation process for you?
• Who needs to be convinced internally before you can select a vendor, and what evidence will they require? Options: QA/RA, Clinical Ops, Finance, Procurement, Lab Director, Executive Sponsor, Other

Quick Snapshot: Where We Stand Today

• Roughly how many clinical samples does your program move per month? Options: 0–1,000, 1,001–10,000, 10,001–50,000, 50,001–200,000, 200,000+
• Which regions and countries do your shipments most frequently traverse? Options: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa, Other/Specific list
• What are the primary specimen types in your workflow (select all that apply)? Options: Whole blood, Plasma/serum, PBMCs, Tissue/biopsies, Urine, Stool, Investigational products/IMP, Other
• Briefly describe your typical end-to-end flow from site collection to final lab/biorepository (key handoffs, expected timelines).
• Which internal teams are regularly involved in sample movement and receipt? Options: Clinical operations, Site coordinators, Logistics/operational team, QA/Compliance, Central lab receiving, Biorepository, Vendors/couriers, Other
• How standardized across sites are your collection and packaging procedures? Options: Highly standardized and documented, Mostly standardized with some site variation, Significant variation by site or country, Not standardized

When the Sample Leaves the Site, What’s the Real Story?

• When the site hands a sample to a courier or lab, how confident are you that nothing critical is lost in that handoff? Options: Very confident, Somewhat confident, Occasionally concerned, Frequently concerned
• Who physically completes the handoff at the site and who signs/records custody? Options: Site nurse/coordinator, Phlebotomist, Courier driver, Site lab tech, Automated dropbox, Other
• What packaging or temperature-control solutions are used at collection (e.g., passive coolers, active shippers, conditioned containers)? Options: Standard insulated box with cold packs, Validated passive thermal shipper, Active temperature-controlled container, Ambient packaging, Site-provided ad hoc packaging, Other
• How is chain-of-custody documented at handoff (pick all that apply)? Options: Paper COC form, Courier mobile app signature, Barcode scan logged to LIMS/portal, Photo evidence, No formal record, Other
• Describe any recent handoff incident that caused rework or delay and how it was detected.
• How long after collection do samples typically reach the receiving lab (average & range)? Options: <12 hours, 12–24 hours, 24–48 hours, 48–72 hours, >72 hours

Where Things Break: The Small Glitches That Become Big Problems

• If you had to point to one bottleneck or handoff that creates the most costly failures, what would it be? Options: Site packaging/labeling errors, Courier handoffs/transfers, Customs/clearance delays, Lab receiving backlog, Temperature control failures, Integration/data handoffs
• Which failure modes have you observed in the last 12 months and how often (estimate frequency)? Options: Temperature excursion, Mislabeling or ID mismatch, Missing/incomplete COC, Courier lost/delayed shipment, Damaged packaging, Customs hold
• When failures occur, how are they typically discovered? Options: Real-time telemetry alert, Receiving lab notice, Routine QC check, Auditor inquiry, Site report, Other
• What is the most common root cause you’ve identified (human error, packaging, carrier handoff, customs, other)? Options: Human/site error, Inadequate packaging/validation, Carrier handoff process, Regulatory/customs hold, Data/integration gaps, Other
• Share one example of a failure that led to invalidated data or unusable samples — what happened and what did it cost you (time/resources)?
• How often do you see incidents that are only discovered retrospectively during audit or data reconciliation? Options: Almost always, Often, Occasionally, Rarely, Never

Systems & Visibility: Are You Looking at a Timeline or a Silo?

• Do your current systems provide a single, auditable timeline for each sample or do you rely on multiple disconnected records? Options: Single integrated timeline (LIMS/TMS integrated), Mostly integrated with some manual steps, Multiple disconnected systems with manual reconciliation, Primarily manual/paper-based
• Which systems do you use today to track custody and status (select all that apply)? Options: LIMS, CTMS, Transport Management System (TMS), Courier portals, Custom database/Excel, Temp monitoring portal (IoT), Other
• Are barcode scans or other automated identity verifications enforced at each transfer point? Options: Yes, at every transfer, Yes, but inconsistently, Only at major nodes (site/lab), No, mostly manual verification
• Where do you store chain-of-custody evidence and how long is it retained? Options: Central LIMS/electronic archive, Courier portal + local copies, Paper files at sites, Distributed across systems, Unsure
• What manual reconciliation steps are required today to match physical samples to digital records?
• How frequently do you run reconciliations or audits of custody data, and who owns that process? Options: Daily, Weekly, Monthly, Quarterly, Event-driven, No regular reconciliation

Audit Day: Could You Recreate the Whole Story in Hours, Not Weeks?

• If an auditor requested the full chain-of-custody for a high-value sample, how quickly could you produce complete evidence? Options: <48 hours, 2–5 days, 1–2 weeks, More than 2 weeks, Unable to produce reliably
• Which pieces of evidence are most frequently incomplete during audits (pick all that apply)? Options: COC signatures, Temperature logs, Barcode/ID scans, Customs/clearance records, Courier transfer notes, Receiving lab logs
• Describe any recurring audit findings related to chain-of-custody or sample integrity from the past 2 years.
• Where do you see the largest evidence gaps — geography, specific sites, vendor handoffs, or system interfaces? Options: Specific countries/regions, Select problematic sites, Third-party couriers, Integration points between systems, All of the above, Other
• What would change internally if you could guarantee audit-ready, end-to-end evidence for every sample?

Temperature, Identity, and Integrity: Which One Keeps You Awake?

• Which of the three controls—temperature monitoring, identity verification, or documented custody—do you consider the highest current risk? Options: Temperature monitoring, Identity verification (labeling/barcodes), Documented custody/COC completeness, All equally risky
• What temperature-monitoring technology do you currently use (select all that apply)? Options: Single-use data loggers, Reusable data loggers, Real-time IoT trackers with telemetry, No temperature monitoring, Manual spot checks, Other
• When a temperature excursion is detected, what is your standard response workflow? Options: Automated alert → defined CAPA, Manual review then escalate, Notify site/shipper → hold/decide, No formal workflow defined
• How often do excursions or identity mismatches lead to sample rejection or re-collection? Options: Regularly (monthly), Occasionally (quarterly), Rarely (annual), Never/not tracked
• Describe a recent temperature or ID incident, how it was handled, and the ultimate outcome.

The Real Cost: What’s It Really Taking From You?

• When you quantify the last major chain-of-custody failure, which impact categories saw the biggest hit (select all that apply)? Options: Invalidated assay data, Delayed regulatory milestones, Direct financial loss (reshipping/retesting), Increased QA workload, Reputational impact with sponsors/sites, Other
• Estimate how many staff-hours are typically consumed resolving a single custody/temperature incident. Options: <5 hours, 5–20 hours, 20–50 hours, 50–200 hours, 200+ hours
• Have custody failures ever triggered a formal regulatory action, finding, or major sponsor escalation for your program? Options: Yes — regulatory action, Yes — formal sponsor escalation, Yes — internal incident only, No
• How do recurring operational issues influence sponsor confidence or your vendor selection process?
• What internal costs or delays would you most like to reduce in the next 12 months? Options: Sample rejection rate, Time to reconcile custody records, Number of manual interventions, Audit findings related to custody, Lead time to resolve excursions

Small Wins: What Could You Fix Fast to Change Trajectory?

• If you could fix one thing in 90 days that would materially reduce invalid samples or audit risk, what would it be?
• Which of these quick actions would your team be willing to pilot within a single region or study? Options: Standardized validated packaging pilot, Real-time telemetry rollout, Barcode-only custody enforcement, Centralized COC digitization, Courier SOP harmonization
• What internal stakeholders must be involved to approve a pilot (select all that apply)? Options: Clinical ops, QA/Compliance, Procurement, IT/Integrations, Site management, External vendor/courier
• What objective metric would make a pilot a clear success (e.g., % reduction in excursions, time to evidence retrieval, sample rejection rate)? Options: % reduction in excursions, % reduction in invalid samples, Time to produce COC evidence, Reduction in manual reconciliations, Other/compound metric
• How quickly could your organization make a decision to run a limited pilot once a scope and ROI are presented? Options: Immediately, Within 1 month, 1–3 months, 3–6 months, Longer/needs executive approval

Next Steps: If We Were Mapping This Together, What Would You Want to Show First?

• Which deliverable would be most persuasive for your stakeholders coming out of a current-state mapping session? Options: Annotated end-to-end process map, Heatmap of failure modes by node, Audit evidence gap report, Quick-win pilot plan with ROI, Integration roadmap
• Who would need to be present from your organization to make a discovery session actionable? Options: Clinical operations lead, QA/Compliance lead, Logistics/operations manager, IT/LIMS owner, Site operations representative, Vendor/courier rep
• What concerns or objections would you anticipate from those stakeholders about changing the current flow?
• Are you open to a short, evidence-based readiness assessment that benchmarks your custody maturity against regulatory expectations? Options: Yes — ready now, Interested — need more info, Maybe later, No
• Any final specifics we should know about when preparing a tailored current-state mapping for your program (key sites, recent incidents, regulatory timelines)?

Quick Check: Where Are We Right Now?

• What is your target go‑live window for this site or region? Options: Within 2 weeks, 2–4 weeks, 1–3 months, 3–6 months, 6+ months
• How many collection sites and receiving labs are included in this rollout? Options: 1–5, 6–20, 21–100, 100+
• Roughly how many samples per week do you expect each active site to collect once live? Options: <10, 10–50, 51–200, 200–500, 500+
• Who is the single operational owner we should coordinate with for day‑to‑day readiness (name, role, email)?
• Do you already have signed courier and kit‑provisioning agreements for this region? Options: All signed, Partially signed, Negotiations ongoing, Not started

Why Are We Still Waiting?

• What is the one blocker that, if unresolved, will push your go‑live date? Options: Site access/credentials, Customs / import permits, Courier capacity/coverage, LIMS/CTMS integration, Training completion, Kit inventory shortfall, Other
• For that blocker, what is the concrete next milestone and target date to remove it?
• Have you experienced similar blockers in previous rollouts—how long did resolution typically take? Options: <48 hours, 3–7 days, 1–4 weeks, More than a month, No prior experience
• Who internally is accountable for removing this blocker, and who is their backup?
• How would a further delay affect study timelines, regulatory milestones, or site relationships? Options: Minor impact, Moderate rework, Significant delay to timelines, Regulatory submission risk

If This Fails, What Breaks First?

• Which single failure mode worries you most during the first 90 days post‑go‑live? Options: Temperature excursion leading to assay invalidation, Mislabeling / ID errors, Missing chain‑of‑custody documentation, Courier failed pickup/delivery, LIMS sync failures, Customs clearance delays
• Tell us about the last time that failure mode happened—what were the downstream consequences?
• How quickly do you expect to detect and resolve that failure in an ideal state? Options: <1 hour, 1–4 hours, 4–24 hours, 1–3 days, Longer
• What are your minimum acceptable recovery actions (e.g., re‑collect window, quarantine protocol, audit packet) when that risk occurs? Options: Re‑collect mandated, Quarantine and notify sponsor, Use alternate kit and document deviation, Retrospective corrective action only, Other
• What evidence does your QA/Regulatory team require to close the loop on such an incident? Options: Temperature logs with timestamps, Courier chain‑of‑custody records, Barcode scans at every transfer, Corrective action report, Photographic evidence, Other

Who's Actually Running the Show?

• Do you have clearly assigned operational owners and alternates for site access, kit provisioning, courier coordination, and receiving? Options: Yes, all roles defined, Partially defined, Role definitions in progress, No, not defined
• Please list the named owners for Site Ops, Courier Ops, Lab Receiving, and QA with phone/email for each.
• Which stakeholders must sign final 'ready for launch' approval (select all that apply)? Options: Clinical Operations, QA/Regulatory, Lab Director, Supply Chain/Logistics, Vendor Ops, CTMS/LIMS Team
• How comfortable are those stakeholders with the current level of documentation and test evidence? Options: Fully comfortable, Mostly comfortable, Some concerns, Not comfortable at all
• If a named owner becomes unavailable during go‑live, what is the escalation path and backup decision authority?

Can We Prove It's Working Before Go‑Live?

• If we ran a full end‑to‑end dry run tomorrow, what would need to be true for you to call it successful? Options: Temperature integrity verified, All barcodes scanned and matched, COC documentation complete, LIMS records synchronized, Courier pickup and delivery on time
• Which of the following acceptance tests are already passing in your environment? Options: Temperature profile test, Barcode scan traceability, Electronic COC completeness, LIMS/CTMS data flow, Courier ETA reliability, None yet
• Who signs the validation checklist and what format is required for audit (e.g., PDF signoff, stamped SOP, electronic signature)? Options: Electronic signature, PDF with signatures, Stamped SOP, Email approval chain, Other
• How many dry runs do you expect before granting final 'go' approval? Options: 1, 2–3, 4–6, Depends on issues found
• Describe any unique environmental or transit conditions we must simulate (e.g., extreme heat, multi‑leg customs holds, long‑haul transits).

If Something Goes Wrong, Who's Calling Whom?

• Do you have a documented incident response and escalation playbook that covers temperature excursions, lost shipments, and data sync failures? Options: Comprehensive playbook exists, Playbook exists but partial, Playbook draft, No playbook
• What is your desired notification timeline for critical events (e.g., initial alert, incident report, root cause), and via which channels? Options: Immediate push + email, Email within 1 hour, Phone for critical only, Daily summary, Other
• Do you require dedicated incident war‑room support (vendor + sponsor + lab) for the first X weeks? If so, how long? Options: No, First 1 week, First 2 weeks, First month, Custom duration
• What spare parts or kit buffers must be staged locally (e.g., spare coolers, replacement reagents, extra barcoded kits) and in what quantities?
• Which authorities or internal teams must be copied on incident reports (select all that apply)? Options: QA, Clinical Ops, Lab Director, Regulatory, Vendor Ops, Project Management

What Would Make You Sleep Better the Night Before Launch?

• If you could require one non‑negotiable guarantee from your logistics partner before go‑live, what would it be? Options: Real‑time temp alerts within 5 minutes, 100% barcode scan rate, Alternate courier guarantee, Regulatory‑grade COC documentation, On‑site kickoff support
• What KPIs and reporting cadence would make you confident in the first 30, 60, and 90 days? Options: Daily KPI summary, Weekly deep‑dive, Real‑time dashboard access, Monthly executive report
• What training or materials still need to be completed for site staff and lab receivers (select all that apply)? Options: In‑person training, Live webinar, On‑demand videos, Quick reference guides, SOP updates, No additional training needed
• Who will be the final signatory that confirms site readiness and accepts the mutual commit for this deployment?
• What remaining documentation or evidence would immediately change your readiness status from 'concerned' to 'confident'?

Who's in the Room (and Who Decides?)

• Who on your team is ultimately accountable for sample chain-of-custody and release decisions? Options: Clinical Supply Director, Biorepository Director, QA/Compliance Lead, Laboratory Operations Manager, Other
• Who else needs to be involved in conversations about timelines, regulations, and day-to-day operations for sample movement? Options: Clinical Operations, Investigators/Site Coordinators, CTMS/LIMS Administrators, Vendors/Couriers, Regulatory Affairs, Other
• How do you prefer decisions to be documented and escalated—formal change control, weekly steering notes, or ad-hoc emails? Options: Formal change control, Weekly steering notes, Operational runbook updates, Ad-hoc emails/threads, Other
• What’s the typical timeline from decision to operational change for sample logistics topics in your organization? Options: <2 weeks, 2–6 weeks, 6–12 weeks, 3+ months, Varies greatly
• Is there anyone we should avoid contacting directly (e.g., vendor relationships handled centrally)? If yes, why?

When a Sample Fails, Who Feels It Most?

• When a transit or documentation failure happens, what single consequence hurts your program most—data loss, regulatory exposure, cost, or timelines? Options: Invalidated assay/data loss, Regulatory findings/inspection risk, Study timeline delays, Increased cost/rework, Reputation with sites/investigators
• Tell us about the last high-impact incident you had with sample integrity or chain-of-custody—what happened and how long did recovery take?
• How often do you experience temperature excursions, mislabeling, or missing COCs at the lab that require investigation? Options: Weekly, Monthly, Quarterly, Rarely, Never
• When those incidents occur, who owns the root-cause investigation and who signs off on remediation? Options: Clinical Ops, QA/Compliance, Lab Operations, Third-party Vendor, Shared responsibility
• How does an unresolved logistics failure make you feel about meeting upcoming regulatory milestones or submissions? Options: Very concerned, Somewhat concerned, Neutral, Confident

Where Are the Leaks You’ve Learned to Live With?

• What recurring day-to-day handoffs or processes do you suspect are the biggest sources of error? Options: Site collection to courier pickup, Courier-to-lab handoff, Packaging/kit provisioning, LIMS logging at receipt, Temperature monitoring review, Other
• Which failure modes have you already instrumented metrics for (e.g., on-time receipt, temp excursions), and which ones are essentially invisible today? Options: On-time receipt, Temperature excursion rate, Barcode mismatches, COC completeness, Chain-of-custody timestamps, None instrumented
• Describe a moment when paper or missing evidence made reconstruction for an auditor impossible—what did you wish you had captured?
• What systems currently touch sample status (LIMS, CTMS, your TMS, courier portals) and where do updates break down? Options: LIMS, CTMS, TMS/Transportation system, Courier portal(s), ERP/wms, Other
• How fragmented is responsibility across vendors for packaging, courier, temp-monitoring, and lab receiving? Options: Single integrated provider, Two providers (e.g., courier + monitoring), Multiple separate vendors, All managed internally

If Regulators Asked Tomorrow, Could You Prove It?

• What would a regulator most likely question about your current chain-of-custody evidence if they opened your trial file today? Options: Missing timestamps, Incomplete COCs, Unverified temperature data, Unclear custody transfers, Lack of SOP/audit trail
• Have you had regulatory observations or audit findings related to sample logistics in the past 3 years? If yes, what were the root causes? Options: Yes — documentation gaps, Yes — temperature excursions, Yes — labeling issues, No, Prefer not to say
• How would you rank the following as barriers to producing audit-ready evidence: people, processes, systems, or vendor SLAs? Options: People, Processes, Systems/IT, Vendor SLAs, All about equal
• What documentation package would make you confident to share chain-of-custody with a regulator (e.g., time-stamped COC + raw temp trace + scanned manifest)? Options: Time-stamped COC + signatures, Raw temp sensor trace, Barcode scan logs, Integrated LIMS transfer record, All of the above
• How quickly do you need to assemble a regulatory evidence package when an auditor requests it? Options: Immediately (hours), Within 24–48 hours, Within a week, Longer than a week

If You Could Erase One Failure Mode, Which Would Change Everything?

• If you could eliminate one recurring sample logistics problem overnight, which would it be and why? Options: Temperature excursions, Mislabeling/barcode mismatches, Incomplete COCs, Courier handoff gaps, Delayed receipts
• What downstream cost or risk would be avoided if that single problem didn’t occur (e.g., fewer re-collections, faster submissions)?
• What have you tried previously to address that issue, and what stopped it from sticking?
• How important is it that the fix integrates with your LIMS/CTMS rather than being a bolt-on reporting layer? Options: Critical — full integration required, Desirable but not mandatory, Nice to have, Not necessary
• If we could design a short pilot to prove the fix, what measurable outcome would convince you it works? Options: Reduction in excursions, 100% COC completeness, Faster time-to-receipt, Full audit traceability, Reduced root-cause investigations

How Do You Define 'Good' for Sample Logistics?

• Which KPIs do you consider mission-critical for sample integrity and why? Options: On-time receipt, Temperature compliance rate, COC completeness, Barcode scan match rate, Time to reconcile exceptions
• What target thresholds do you aim for today for those KPIs (please specify numeric targets where possible)?
• How often do you review these KPIs and with whom? Options: Daily, Weekly, Monthly, Quarterly, On ad-hoc incident
• What escalation steps do you expect when an SLA is missed—automated alerts, vendor penalty, immediate root-cause meeting, or something else? Options: Automated alert + Ops owner, Escalation to QA/Compliance, Vendor penalty clause, Immediate corrective action meeting, Other
• Which KPI would you prioritize for a first pilot/POC if we had to pick only one to prove value quickly? Options: Temperature integrity rate, COC completeness, On-time receipt percentage, Barcode reconciliation rate, Time to close exceptions

If We Ran a Pilot, What Would Success Look, Feel, and Prove?

• What geographic scope, sample types, and site volume would you want included in an initial pilot to meaningfully de-risk a roll-out?
• What would make you say the pilot was an unambiguous success—concrete KPIs, stakeholder sign-offs, or regulatory comfort? Options: Concrete KPI improvement, Stakeholder (OPS/QA) sign-off, Audit-grade evidence package, Smooth integration with LIMS/CTMS, All of the above
• What operational ownership and governance would you require during the pilot (e.g., weekly review calls, dedicated ops lead, shared runbook)? Options: Weekly review calls, Dedicated ops lead, Shared runbook/SOP, Ad-hoc as needed, Other
• What are the non-negotiables (regulatory, contractual, or technical) that would stop a pilot from being acceptable?
• Realistically, how soon could you commit the people and sites needed to run a meaningful pilot? Options: Immediately, Within 1 month, 1–3 months, 3+ months, Unsure